17th Annual Diabetes Symposium
The 17th Annual Diabetes Symposium will be held virtually by Baylor St. Luke's Medical Center. The Diabetes Symposium is a one-day course designed to provide endocrinologists, primary care physicians, cardiologists, and associated professionals with updated information on novel and optimal therapies for the treatment of diabetes, including evidence-based intervention strategies, weight reduction strategies, new diabetes technologies and insulin formulations, and more.
The 2023 Symposium will be held in October of this year. Please check back later for the registration link.
|7:45 am||Welcome / Opening Remarks||Mandeep Bajaj, M.D., FRCP|
|8:00 a.m.||GLP-1 Receptor Agonists in Type 2 Diabetes||Ralph DeFronzo, M.D.|
|9:00 a.m.||SGLT-2 Inhibitors and Chronic Kidney Disease in Type 2 Diabetes||Sankar Navaneethan, M.D.|
|10:00 a.m.||Break||Yochai Birnbaum, M.D., FAHA, FACC|
|10:10 a.m.||Diabetes and Heart Failure|
|11:10 a.m.||Cardiovascular Risk Reduction in Type 2 Diabetes||Vijay Nambi, M.D.|
|12:10 p.m.||Lunch / Exhibitor Hall (Expo)|
|1:00 p.m.||Newer Insulins||Tom Thomas, D.O.|
|2:00 p.m.||Weight Management in Patients with Type 2 Diabetes||Osama Handy, M.D.|
|3:10 p.m.||Managing Diabetes in Hospitalized Patients with Covid-19||Guillermo Umpierrez, M.D., CDE|
|4:10 p.m.||Insulin Pumps and Continuous Glucose Monitoring Systems||Celia Levesque, NP, MSN, CNS, CDE|
|5:10 p.m.||Q&A / Evaluations||Mandeep Bajaj, M.D., FRCP|